These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 17724373)

  • 1. 2-cyano-lup-1-en-3-oxo-20-oic acid, a cyano derivative of betulinic acid, activates peroxisome proliferator-activated receptor gamma in colon and pancreatic cancer cells.
    Chintharlapalli S; Papineni S; Liu S; Jutooru I; Chadalapaka G; Cho SD; Murthy RS; You Y; Safe S
    Carcinogenesis; 2007 Nov; 28(11):2337-46. PubMed ID: 17724373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 2-Cyano-3,12-dioxoolean-1,9-dien-28-oic acid and related compounds inhibit growth of colon cancer cells through peroxisome proliferator-activated receptor gamma-dependent and -independent pathways.
    Chintharlapalli S; Papineni S; Konopleva M; Andreef M; Samudio I; Safe S
    Mol Pharmacol; 2005 Jul; 68(1):119-28. PubMed ID: 15798084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methyl 2-cyano-3,11-dioxo-18 beta-olean-1,12-dien-30-oate is a peroxisome proliferator-activated receptor-gamma agonist that induces receptor-independent apoptosis in LNCaP prostate cancer cells.
    Papineni S; Chintharlapalli S; Safe S
    Mol Pharmacol; 2008 Feb; 73(2):553-65. PubMed ID: 17989348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1,1-Bis(3'-indolyl)-1-(p-substitutedphenyl)methanes are peroxisome proliferator-activated receptor gamma agonists but decrease HCT-116 colon cancer cell survival through receptor-independent activation of early growth response-1 and nonsteroidal anti-inflammatory drug-activated gene-1.
    Chintharlapalli S; Papineni S; Baek SJ; Liu S; Safe S
    Mol Pharmacol; 2005 Dec; 68(6):1782-92. PubMed ID: 16155208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-dependent activity of glycyrrhetinic acid derivatives as peroxisome proliferator-activated receptor {gamma} agonists in colon cancer cells.
    Chintharlapalli S; Papineni S; Jutooru I; McAlees A; Safe S
    Mol Cancer Ther; 2007 May; 6(5):1588-98. PubMed ID: 17513608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peroxisome proliferator-activated receptor-gamma contributes to the inhibitory effects of Embelin on colon carcinogenesis.
    Dai Y; Qiao L; Chan KW; Yang M; Ye J; Ma J; Zou B; Gu Q; Wang J; Pang R; Lan HY; Wong BC
    Cancer Res; 2009 Jun; 69(11):4776-83. PubMed ID: 19458067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of bladder tumor growth by 1,1-bis(3'-indolyl)-1-(p-substitutedphenyl)methanes: a new class of peroxisome proliferator-activated receptor gamma agonists.
    Kassouf W; Chintharlapalli S; Abdelrahim M; Nelkin G; Safe S; Kamat AM
    Cancer Res; 2006 Jan; 66(1):412-8. PubMed ID: 16397256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rhodanine derivatives as novel peroxisome proliferator-activated receptor gamma agonists.
    Liu Q; Zhang YY; Lu HL; Li QY; Zhou CH; Wang MW
    Acta Pharmacol Sin; 2007 Dec; 28(12):2033-9. PubMed ID: 18031620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peroxisome proliferator-activated receptor delta and gamma agonists differentially alter tumor differentiation and progression during mammary carcinogenesis.
    Yin Y; Russell RG; Dettin LE; Bai R; Wei ZL; Kozikowski AP; Kopelovich L; Glazer RI
    Cancer Res; 2005 May; 65(9):3950-7. PubMed ID: 15867396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 1,1-Bis(3'-indolyl)-1-(p-substitutedphenyl)methanes induce peroxisome proliferator-activated receptor gamma-mediated growth inhibition, transactivation, and differentiation markers in colon cancer cells.
    Chintharlapalli S; Smith R; Samudio I; Zhang W; Safe S
    Cancer Res; 2004 Sep; 64(17):5994-6001. PubMed ID: 15342379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclic phosphatidic acid decreases proliferation and survival of colon cancer cells by inhibiting peroxisome proliferator-activated receptor γ.
    Tsukahara T; Hanazawa S; Kobayashi T; Iwamoto Y; Murakami-Murofushi K
    Prostaglandins Other Lipid Mediat; 2010 Nov; 93(3-4):126-33. PubMed ID: 20932931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peroxisome proliferator-activated receptor gamma agonists inhibit adipocyte expression of alpha1-acid glycoprotein.
    Castriota G; Thompson GM; Lin Y; Scherer PE; Moller DE; Berger JP
    Cell Biol Int; 2007 Jun; 31(6):586-91. PubMed ID: 17240171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of PPARgamma is not involved in butyrate-induced epithelial cell differentiation.
    Ulrich S; Wächtershäuser A; Loitsch S; von Knethen A; Brüne B; Stein J
    Exp Cell Res; 2005 Oct; 310(1):196-204. PubMed ID: 16112107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 6-Shogaol inhibits breast and colon cancer cell proliferation through activation of peroxisomal proliferator activated receptor γ (PPARγ).
    Tan BS; Kang O; Mai CW; Tiong KH; Khoo AS; Pichika MR; Bradshaw TD; Leong CO
    Cancer Lett; 2013 Aug; 336(1):127-39. PubMed ID: 23612072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Herbal isoprenols induce apoptosis in human colon cancer cells through transcriptional activation of PPARgamma.
    Au-Yeung KK; Liu PL; Chan C; Wu WY; Lee SS; Ko JK
    Cancer Invest; 2008 Aug; 26(7):708-17. PubMed ID: 18608213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic analysis of peroxisome proliferator-activated receptor gamma1 splice variants in human colorectal cell lines.
    Fiatte C; Huin C; Bertin I; Lesuffleur T; Pluvinet A; Touche N; Plénat F; Dauça M; Domenjoud L; Schohn H
    Int J Oncol; 2006 Dec; 29(6):1601-10. PubMed ID: 17089002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mycophenolic acid as a latent agonist of PPARgamma.
    Ubukata M; Takamori H; Ohashi M; Mitsuhashi S; Yamashita K; Asada T; Nakajima N; Matsuura N; Tsuruga M; Taki K; Magae J
    Bioorg Med Chem Lett; 2007 Sep; 17(17):4767-70. PubMed ID: 17618115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low expression of ORF4, a dominant negative variant of peroxisome proliferator-activated receptor gamma, in colorectal adenocarcinoma.
    Bouancheau D; Jarry A; Mottier S; Toquet C; Masson D; Mosnier JF; Laboisse CL; Denis MG
    Oncol Rep; 2007 Aug; 18(2):489-95. PubMed ID: 17611675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of COX-2 and activation of peroxisome proliferator-activated receptor gamma synergistically inhibits proliferation and induces apoptosis of human pancreatic carcinoma cells.
    Sun WH; Chen GS; Ou XL; Yang Y; Luo C; Zhang Y; Shao Y; Xu HC; Xiao B; Xue YP; Zhou SM; Zhao QS; Ding GX
    Cancer Lett; 2009 Mar; 275(2):247-55. PubMed ID: 19056168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peroxisome proliferator-activated receptor gamma overexpression suppresses proliferation of human colon cancer cells.
    Tsukahara T; Haniu H
    Biochem Biophys Res Commun; 2012 Aug; 424(3):524-9. PubMed ID: 22771328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.